Document Migration

WHITE PAPERS AND CASE STUDIES

• Digital Transformation: A Critical Component For CDMOs

  Learn how embracing the digital transformation is key for managing complexity of speed, service, quality, regulatory compliance, and capacity as well as the obstacles facing CDMOs looking to innovate.

• The Rise Of The Clinical Research Network: Using Technology To Connect Sites And Sponsors

  Explore how an integrated approach to the clinical research industry’s technology landscape can remove friction, improve access, save time, and better serve patients.

• eSource Enables Speed, Flexibility, And Higher-Quality Data

  A truly integrated eSource Solution, including DDC, eCOA, and eConsent, facilitates remote or decentralized clinical trials by ingesting data from multiple sources and consolidating it into a single data set.

• 3D Scanning System Brings Digital Characters To Life

  Explore how advancements in visual effects, driven by high-speed 3D digital capture systems from Pixel Light Effects, are transforming the entertainment industry.

• The Regulatory Evolution And Data Revolution In Medical Device Development

  The Life Sciences and Healthcare industries are among the most heavily regulated industries in the world. This paper looks at the current, dynamic regulatory landscape within the medical devices sector and some of the current and future changes medical device organizations will need to adhere to. The in-vitro diagnostics (IVD) sector is also going through regulatory change - a topic that is out of scope for this paper.

• Yorkshire Water Reduces Leaks By 57%, Eliminating 30% Of Annual Distribution Main Repairs

  Yorkshire Water Services (YWS) is a leading UK water utility that serves nearly 5.5 million people and has a well-deserved reputation as a progressive and proactive utility. Their belief that innovation is one of the key driving forces that allows utilities to deliver better services to their customers while keeping costs down has led them to always seek out new ways to improve their operations both now and in the future.

• An Experienced CDMO Can Be A Differentiator In The Rapidly Growing Biologics Market

  Biotech and biopharma developers are increasingly relying on outsourcing partners to meet both clinical and commercial research, development, and production needs. CDMOs that provide end-to-end services, including secure supply chains, can help biologics developers meet accelerated timelines and establish a real competitive advantage in today’s competitive market.

• Gateways To Asia: Market Access In Japan And South Korea

  Learn how the recent developments in market access and regulatory rules in Japan and South Korea have paved the way for expansion in Asia.

• Back To Basics: A Survey Of Clinical Data Management System Users And Decision Makers

  A survey was conducted, asking participants about their current pain points, current CDMS solutions, and features/functionalities they desire in a future CDMS. This white paper discusses the key results of this survey.

• Effective Communication Drives Successful Manufacturing Transfers And Productive CMO Relationships

  While lift-and-shift scenarios — wherein manufacturing is moved from one site to another without product or manufacturing process redesign —are ideal, they also are a rarity.

• Assessing End-To-End Drug Development Partnerships

  As drug development becomes increasingly expensive and complex, pharma companies are relying on CDMOs to maximize efficiencies. Examine the opportunities and challenges of end-to-end arrangements.

• DCTs: What Are They And What Are The Direct Impacts To DMs?

  In 2020, the need for alternative approaches to clinical trial execution and data capture became a reality overnight. The concept of implementing components of decentralization within a clinical trial became one of ‘here and now,’ versus a concept of the future.